Search for: "Global Gear & Machine Co., Inc" Results 1 - 15 of 15
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jun 2009, 10:00 pm
(IP finance) International bank of IP: a proposal for knowledge liberalisation (IPKat) How to fight fakes in a down economy (Managing Intellectual Property) Global - Patents Nations work to make IP systems combat climate change (Intellectual Property Watch) When prioritising IP, look to green tech (Technology Transfer Tactics) Global - Copyright What is the (copy)right way to maximise IP rights upon insolvency? [read post]
9 May 2008, 10:30 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Order to transfer myspace.co.uk to MySpace overturned: (Out-Law), (IMPACT), New branding scheme for Ethiopian coffees: (Afro-IP), (IP finance), (IPKat), USPTO to appeal Tafas/GSK v Dudas: (Patent Docs), (Patently-O), (PLI), (Patent Baristas), (Managing Intellectual Property), (IP Law360), (Patent Prospector), (Ladas & Parry),… [read post]
1 Nov 2008, 3:12 am
(Ars Technica) CAFC: Co-inventors contribution must be 'more than the exercise of ordinary skill'; NTP awarded attorneys' fees: Oren Tavory v NTP (Patently-O) (Law360) (Law360) (Property, intangible) (Patent Prospector) (Property, intangible) PTO announces no IDS or Markush Rules during Bush Administration (Patent Prospector) (Hal Wegner) (Patently-O) (Patent Docs)   Global Global - General Exploding the intangible asset market cap myth (IP… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
30 May 2008, 9:09 am
: (IP ThinkTank), (further discussion from IAM and e^(ip)) Illusory world of trade secret protection – Discussion of S Schreter’s article ‘Inside entrepreneurship: Patent protection isn’t only option’: (IPBiz)   Global – Copyright Illegal art: (Patry Copyright Blog),     Events 1-3 June: ACC Europe 2008 annual conference ‘Becoming a global legal manager: Developing the skills you will… [read post]
9 Jan 2009, 7:00 am
(Spicy IP) Sindh High Court to hear Basmati trade mark issue (The Trademark Blog) Indian patent examiners inching at par with global counterparts (Patent Circle) Perspectives on the promotion of innovation (Spicy IP) Spicy IP questionnaire on interim injunctions: is it time for change? [read post]
4 Jan 2024, 4:28 am by Rob Robinson
This webinar is geared towards novices and experts alike who want to stay abreast of the latest M365 Purview eDiscovery advancements. [read post]
24 Jul 2019, 10:00 am by Kristian Soltes
AmEx Posts a 6% Jump in Global Discount Revenue As Overall Revenue Rises 8%Digital Transactions News – July 19, 2019 American Express Co. on Friday reported worldwide discount revenue of $6.58 billion for the quarter ended June 30, up 6% year-over-year. [read post]
6 Apr 2017, 4:00 am by Administrator
Michael Maschke, CEO of Sensei Enterprises, Inc. [read post]
30 Nov 2011, 2:15 pm by Mandelman
Okay, so here’s the next installment of Mandelman’s Monthly Museletter, which I’ve decided I post whenever there are a bunch of things going on that need to be put into proper perspective, but there’s just no way I can write individual articles on each because to do so presents a serious health risk. [read post]